Clinical Trials Centre
The World Health Organisation (WHO) definition for a clinical trial is:
‘any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes’.
Clinical trials are conducted to test the effectiveness and safety of new treatments, therapies, and management and prevention techniques. Clinical trials involve real people and patients as volunteers.
For example, clinical trials can help;
- prevent diseases by testing a vaccine
- detect or diagnose diseases or conditions, for example by testing a blood sample
- treat diseases or conditions by testing a new medicine or other medical procedure
- discover ways people can control their symptoms or improve their quality of life by testing particular lifestyle factors and how they can affect a condition.
Clinical trials also contribute to improved health care services by raising standards of treatment. Doctors and hospital staff involved in clinical trials are continually trained to provide best practice patient care.
There are different types of clinical trials. Most of the trials at WMR are driven by clinicians and health care providers and are funded by philanthropic donors for the public good. We also conduct commercially-sponsored clinical trials to test new products in the pipeline of pharmaceutical companies.
Every clinical trial has different guidelines as to who can or cannot participate to help investigators achieve accurate and meaningful results.
These guidelines are called eligibility criteria and describe characteristics that must be shared between trial participants.
Clinical Trials Recruiting Participants
We are currently seeking participants for clinical trials investigating new treatments for the following medical conditions:
Wesley Medical Research is committed to undertaking research initiatives that will help discover new ways to diagnose, treat and manage Coeliac Disease. As such, we are actively seeking people to help us with our Clinical Trials.
Parkinson’s disease (PD) currently affects about 40,000 Australians. Even modest therapeutic advances that delay disease onset and progression could significantly reduce the burden of the disease on patients and the level of care required.
MS is the most common acquired chronic neurological disease affecting young adults, often diagnosed between the ages of 20 to 40. For people with MS, participating in clinical research may provide early access to new treatments and an improved quality of life.